Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.

de Keijzer J, Mulder A, de Haas PE, de Ru AH, Heerkens EM, Amaral L, van Soolingen D, van Veelen PA.

J Proteome Res. 2016 Jun 3;15(6):1776-86. doi: 10.1021/acs.jproteome.5b01037. Epub 2016 May 9.

PMID:
27068340
2.

Disclosure of selective advantages in the "modern" sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics.

de Keijzer J, de Haas PE, de Ru AH, van Veelen PA, van Soolingen D.

Mol Cell Proteomics. 2014 Oct;13(10):2632-45. doi: 10.1074/mcp.M114.038380. Epub 2014 Jul 14.

3.

Multiple strains of Mycobacterium avium subspecies hominissuis infections associated with aborted fetuses and wasting in pigs.

Wellenberg GJ, de Haas PE, van Ingen J, van Soolingen D, Visser IJ.

Vet Rec. 2010 Sep 18;167(12):451-4. doi: 10.1136/vr.c4274.

PMID:
20852249
4.

Evaluation of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis infections in Zambia and South Africa.

Muyoyeta M, de Haas PE, Mueller DH, van Helden PD, Mwenge L, Schaap A, Kruger C, Gey van Pittius NC, Lawrence K, Beyers N, Godfrey-Faussett P, Ayles H.

J Clin Microbiol. 2010 Oct;48(10):3773-5. doi: 10.1128/JCM.01688-09. Epub 2010 Aug 4.

5.

Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients.

van Ingen J, Boeree MJ, de Lange WC, de Haas PE, van der Zanden AG, Mijs W, Rigouts L, Dekhuijzen PN, van Soolingen D.

Int J Syst Evol Microbiol. 2009 Apr;59(Pt 4):845-9. doi: 10.1099/ijs.0.001511-0.

PMID:
19329618
6.

Clinical relevance of Mycobacterium szulgai in The Netherlands.

van Ingen J, Boeree MJ, de Lange WC, de Haas PE, Dekhuijzen PN, van Soolingen D.

Clin Infect Dis. 2008 Apr 15;46(8):1200-5. doi: 10.1086/529443.

PMID:
18444856
7.

Tuberculosis outbreaks predicted by characteristics of first patients in a DNA fingerprint cluster.

Kik SV, Verver S, van Soolingen D, de Haas PE, Cobelens FG, Kremer K, van Deutekom H, Borgdorff MW.

Am J Respir Crit Care Med. 2008 Jul 1;178(1):96-104. doi: 10.1164/rccm.200708-1256OC. Epub 2008 Apr 3.

PMID:
18388352
8.

Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to 'bird tuberculosis'.

Bruijnesteijn van Coppenraet LE, de Haas PE, Lindeboom JA, Kuijper EJ, van Soolingen D.

Eur J Clin Microbiol Infect Dis. 2008 Apr;27(4):293-9. doi: 10.1007/s10096-007-0440-z. Epub 2008 Mar 5.

9.

Completeness of notification of tuberculosis in The Netherlands: how reliable is record-linkage and capture-recapture analysis?

van Hest NA, Smit F, Baars HW, De Vries G, De Haas PE, Westenend PJ, Nagelkerke NJ, Richardus JH.

Epidemiol Infect. 2007 Aug;135(6):1021-9. Epub 2006 Dec 7.

10.

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.

van Doorn HR, de Haas PE, Kremer K, Vandenbroucke-Grauls CM, Borgdorff MW, van Soolingen D.

Clin Microbiol Infect. 2006 Aug;12(8):769-75.

11.
12.

Tuberculosis elimination in the Netherlands.

Borgdorff MW, van der Werf MJ, de Haas PE, Kremer K, van Soolingen D.

Emerg Infect Dis. 2005 Apr;11(4):597-602.

13.

Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis.

Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, Van Soolingen D.

Tuberculosis (Edinb). 2004;84(5):337-40.

PMID:
15207809
14.

Analysis of genetic polymorphisms affecting the four phospholipase C (plc) genes in Mycobacterium tuberculosis complex clinical isolates.

Viana-Niero C, de Haas PE, van Soolingen D, Leão SC.

Microbiology. 2004 Apr;150(Pt 4):967-78.

PMID:
15073306
15.

Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Victor TC, de Haas PE, Jordaan AM, van der Spuy GD, Richardson M, van Soolingen D, van Helden PD, Warren R.

J Clin Microbiol. 2004 Feb;42(2):769-72.

16.

Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier?

van Deutekom H, Hoijng SP, de Haas PE, Langendam MW, Horsman A, van Soolingen D, Coutinho RA.

Am J Respir Crit Care Med. 2004 Apr 1;169(7):806-10. Epub 2003 Dec 18.

PMID:
14684559
17.

Nosocomial Mycobacterium bovis-bacille Calmette-Guérin infections due to contamination of chemotherapeutics: case finding and route of transmission.

Vos MC, de Haas PE, Verbrugh HA, Renders NH, Hartwig NG, de Man P, Kolk AH, van Deutekom H, Yntema JL, Vulto AG, Messemaker M, van Soolingen D.

J Infect Dis. 2003 Nov 1;188(9):1332-5. Epub 2003 Oct 15.

PMID:
14593590
18.

False-positive mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequences.

de Boer AS, Blommerde B, de Haas PE, Sebek MM, Lambregts-van Weezenbeek KS, Dessens M, van Soolingen D.

J Clin Microbiol. 2002 Nov;40(11):4004-9.

19.

Mycobacterium microti infection (vole tuberculosis) in wild rodent populations.

Cavanagh R, Begon M, Bennett M, Ergon T, Graham IM, De Haas PE, Hart CA, Koedam M, Kremer K, Lambin X, Roholl P, Soolingen Dv Dv.

J Clin Microbiol. 2002 Sep;40(9):3281-5.

20.

Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases.

Borgdorff MW, Nagelkerke NJ, de Haas PE, van Soolingen D.

Am J Epidemiol. 2001 Nov 15;154(10):934-43.

PMID:
11700248
21.

Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype.

Chan MY, Borgdorff M, Yip CW, de Haas PE, Wong WS, Kam KM, Van Soolingen D.

Epidemiol Infect. 2001 Aug;127(1):169-71.

22.

The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.

van Doorn HR, Kuijper EJ, van der Ende A, Welten AG, van Soolingen D, de Haas PE, Dankert J.

J Clin Microbiol. 2001 Apr;39(4):1591-4.

23.

Restriction fragment length polymorphism typing of mycobacteria.

van Soolingen D, de Haas PE, Kremer K.

Methods Mol Med. 2001;54:165-203. doi: 10.1385/1-59259-147-7:165.

PMID:
21341076
24.

Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands.

de Boer AS, Kremer K, Borgdorff MW, de Haas PE, Heersma HF, van Soolingen D.

J Clin Microbiol. 2000 Dec;38(12):4478-84.

25.
26.

Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates.

de Boer AS, Borgdorff MW, de Haas PE, Nagelkerke NJ, van Embden JD, van Soolingen D.

J Infect Dis. 1999 Oct;180(4):1238-44.

PMID:
10479153
27.

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M, Kremer K, van Embden JD.

J Infect Dis. 1999 Sep;180(3):726-36.

PMID:
10438361
28.

Prevalence of Mycobacterium avium in slaughter pigs in The Netherlands and comparison of IS1245 restriction fragment length polymorphism patterns of porcine and human isolates.

Komijn RE, de Haas PE, Schneider MM, Eger T, Nieuwenhuijs JH, van den Hoek RJ, Bakker D, van Zijd Erveld FG, van Soolingen D.

J Clin Microbiol. 1999 May;37(5):1254-9.

29.

Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism.

Diaz R, Kremer K, de Haas PE, Gomez RI, Marrero A, Valdivia JA, van Embden JD, van Soolingen D.

Int J Tuberc Lung Dis. 1998 Sep;2(9):743-50.

PMID:
9755929
30.

Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers.

van Soolingen D, van der Zanden AG, de Haas PE, Noordhoek GT, Kiers A, Foudraine NA, Portaels F, Kolk AH, Kremer K, van Embden JD.

J Clin Microbiol. 1998 Jul;36(7):1840-5.

31.

Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting.

Van Duin JM, Pijnenburg JE, van Rijswoud CM, de Haas PE, Hendriks WD, van Soolingen D.

Int J Tuberc Lung Dis. 1998 May;2(5):425-9.

PMID:
9613640
32.

Use of IS901 and IS1245 in RFLP typing of Mycobacterium avium complex: relatedness among serovar reference strains, human and animal isolates.

Ritacco V, Kremer K, van der Laan T, Pijnenburg JE, de Haas PE, van Soolingen D.

Int J Tuberc Lung Dis. 1998 Mar;2(3):242-51.

PMID:
9526198
33.

Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting.

Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD.

Am J Epidemiol. 1998 Jan 15;147(2):187-95. Review.

PMID:
9457010
34.

A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa.

van Soolingen D, Hoogenboezem T, de Haas PE, Hermans PW, Koedam MA, Teppema KS, Brennan PJ, Besra GS, Portaels F, Top J, Schouls LM, van Embden JD.

Int J Syst Bacteriol. 1997 Oct;47(4):1236-45.

PMID:
9336935
35.

Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis.

van Soolingen D, de Haas PE, Blumenthal RM, Kremer K, Sluijter M, Pijnenburg JE, Schouls LM, Thole JE, Dessens-Kroon MW, van Embden JD, Hermans PW.

J Bacteriol. 1996 Jan;178(1):78-84.

36.

Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia.

van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P, van Embden JD.

J Clin Microbiol. 1995 Dec;33(12):3234-8.

37.

Molecular epidemiology of tuberculosis in Denmark in 1992.

Yang ZH, de Haas PE, Wachmann CH, van Soolingen D, van Embden JD, Andersen AB.

J Clin Microbiol. 1995 Aug;33(8):2077-81.

38.

Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology.

Hermans PW, Messadi F, Guebrexabher H, van Soolingen D, de Haas PE, Heersma H, de Neeling H, Ayoub A, Portaels F, Frommel D, et al.

J Infect Dis. 1995 Jun;171(6):1504-13.

PMID:
7769285
39.

DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania.

Yang ZH, Mtoni I, Chonde M, Mwasekaga M, Fuursted K, Askgård DS, Bennedsen J, de Haas PE, van Soolingen D, van Embden JD, et al.

J Clin Microbiol. 1995 May;33(5):1064-9.

40.
41.

[Exogenous reinfection with Mycobacterium tuberculosis caused by nosocomial transmission by a patient with AIDS].

van Deutekom H, Claessen FA, Koeleman JG, de Haas PE.

Ned Tijdschr Geneeskd. 1994 Oct 22;138(43):2152-4. Dutch.

PMID:
7969587
42.

Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis.

van Soolingen D, de Haas PE, Haagsma J, Eger T, Hermans PW, Ritacco V, Alito A, van Embden JD.

J Clin Microbiol. 1994 Oct;32(10):2425-33.

43.

DNA fingerprinting of Mycobacterium tuberculosis.

van Soolingen D, de Haas PE, Hermans PW, van Embden JD.

Methods Enzymol. 1994;235:196-205. Review. No abstract available.

PMID:
8057895
44.

Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis.

van Soolingen D, de Haas PE, Hermans PW, Groenen PM, van Embden JD.

J Clin Microbiol. 1993 Aug;31(8):1987-95.

47.

Supplemental Content

Loading ...
Support Center